Tuberculosis that is resistant to first-line and second-line drugs is becoming more prevalent, an international team of experts reported in The Lancet today. They described levels of extensively drug-resistant TB as "alarming". 43.7% of TB (tuberculosis) cases in eight countries were found to be resistant to at least one second-line drug. In a linked Comment in the same journal, Sven Hoffner, from the Swedish Institute for Communicable Disease Control wrote "Most international recommendations for TB control have been developed for MDR TB prevalence of up to around 5%...
More...
More...